| Aarts, Kees (Protix 202202 CEO + Founder) |
Chief Executive Officer (CEO) |
Protix B.V. |
Netherlands |
| Abad-Molina, Maria (AgroSavfe 201402– Head of Product + Business Development before CropDesign) |
Business Development Manager / Strategy Manager |
Biotalys (Group) |
Belgium |
| Abbey, Jeffrey (Jeff) (ImmunOs Therapeutics 202109– COO before Independent Consultant + Novadip Biosciences + Argos Tx) |
Chief Operating Officer (COO) |
ImmunOs Therapeutics AG |
Switzerland |
| Abbott, Rachel (Pan Cancer T 202305– CEO joined as CSO 1/23 before Enara Bio + Adaptimmune) |
Chief Executive Officer (CEO) |
Pan Cancer T B.V. |
Netherlands |
| Abdellaoui, Hautman (RED Horticulture 202311 CFO) |
Chief Financial Officer (CFO) |
RED Horticulture (Rouge Engineered Designs) (Group) |
France |
| Abi-Saab, Walid (Galapagos 201809 CMO) |
Chief Medical Officer (CMO) |
Galapagos (Group) |
Belgium |
| Abou-Jaoudé, Naïm (New York Life 202412 CEO of New York Life Investment Management) |
Chief Executive Officer (CEO) |
New York Life (Group) |
United States (USA) |
| Abraham, Robert (Pfizer 201412 SVP + CSO at Onology Research Unit) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Pfizer (Group) |
United States (USA) |
| Acharya, Anuradha (Ocimum Biosolutions 200408) |
n. a. |
Ficus Enterprises (Group) |
India |
| Adelus, Benoît (Sebia 200802– before Eurofins EVP + bioMérieux CEO + Merial) |
Chief Executive Officer (CEO) |
Sebia (Group) |
France |
| Ahanola, Jani (Noona Healthcare 201611 CEO) |
Chief Executive Officer (CEO) |
Noona Healthcare (FI) |
Finland |
| Ahlberg, Christopher (Spotfire 200505 CEO) |
Chief Executive Officer (CEO) |
TIBCO Software (Group) |
United States (USA) |
| Ahmati, Besmire (Gilde Investment 202306– Associate IR + Fundraising at Gilde Healthcare before PGGM + FMO) |
Public Relations Manager / Investor Relations Manager |
Gilde Investment (Group) |
Netherlands |
| Ajani, Mauro Severino (Cosmo Pharmaceuticals 202404 Board Director) |
Board member, non-executive |
Cosmo Pharmaceuticals (Group) |
Ireland, Republic of |
| Akkermans, Michel |
n. a. |
|
|
| Albert, Winfried (AdnaGen 200810 Managing Director before COO + CSO) |
Managing Director |
Qiagen (Group) |
Germany |
| Albisser, Zeno (Hemispherian 202105 CEO) |
Chief Executive Officer (CEO) |
Hemispherian AS |
Norway |
| Aldag, Jörn (Hookipa Biotech 201606– CEO before Uniqure/AMT + Evotec + MAN GHH) |
Chief Executive Officer (CEO) |
Hookipa (Group) |
Austria |
| Alexander, Jan (Belgian Growth Fund 202007) |
Investment Manager |
Belgian Growth Fund (BGF) |
Belgium |
| Alfheim, Jan A. (Oncoinvent 202006 CEO) |
Chief Executive Officer (CEO) |
Oncoinvent AS |
Norway |
| Ali, Batoul (Instinctif Partners 202305) |
Public Relations Manager / Investor Relations Manager |
Instinctif Partners (Group) |
United Kingdom (GB) |
| Ali, Kevin (Organon 202409 CEO) |
Chief Executive Officer (CEO) |
Organon (Group) |
United States (USA) |
| Aljufalli, Ibrahim (Lifera 202311 Board Chair) |
Board member, non-executive |
Lifera (Group) |
Saudi Arabia |
| Allaer, Didier (Diagenode 201105 CEO) |
Chief Executive Officer (CEO) |
Hologic (Group) |
Belgium |
| Allan, Eva-Lotta (Immunocore 201305– CBO before Ablynx 200606– CBO before Vertex Pharmaceuticals) |
Chief Business Officer (CBO) |
Immunocore (Group) |
United Kingdom (GB) |
| Allen, Debbie (Argen-X 201204 Senior Director Business Development) |
Business Development Manager / Strategy Manager |
Argenx (Argen-X) (Group) |
Netherlands |
| Allen, Peter (Celltech 1992–2004 CFO) |
Board member, non-executive |
UCB (Group) |
United Kingdom (GB) |
| Alloueche, Ali (Affiris 201112– CBO before GSK Biologicals before Novartis Vaccines and Diagnostics) |
Chief Business Officer (CBO) |
Affiris AG |
Austria |
| Alpert, Amir (Immatics 202305 Director Technology Scouting + Development) |
n. a. |
Immatics (Group) |
Germany |
| Altink, Alexander (Kreatech 2000– CEO before van Ommeren & Ceteco) |
Chief Executive Officer (CEO) |
Danaher (Group) |
Netherlands |
| Amar, Frédéric (Esperite 201801 CEO) |
Chief Executive Officer (CEO) |
Esperite (Group) |
Netherlands |
| Ammon (formerly Alexandru), Anca (Ammon Communications 202103 before MorphoSys + Affimed + MacDougall European Office) |
Public Relations Manager / Investor Relations Manager |
Affimed (Group) |
Germany |
| Anacleto, Joe (Bruker 201312 VP of Market Development before AB SCIEX + Life Technologies) |
Business Development Manager / Strategy Manager |
Bruker (Group) |
United States (USA) |
| Ananth, Arun (Proscia 202301 Chief Commercial Officer) |
Chief Commercial Officer (CCO) |
Proscia Inc. |
United States (USA) |
| Andersen, Bente Korsgaard (The Protein Brewery 202209 Board Chair) |
Board member, non-executive |
The Protein Brewery B.V. (TPB) |
Netherlands |
| Andersen, Peter Høngaard (Forbion 202207– Operating Partner before Lundbeck + Novo Nordisk et al) |
Partner (venture partner) |
Forbion (Group) |
Netherlands |
| Anderson, Steve (LabCorp 201904 CSO at Covance) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
LabCorp (Group) |
United States (USA) |
| Andreou, Ioanna (Qiagen 200705 Senior Scientist RnD) |
n. a. |
Qiagen (Group) |
Germany |
| Andriukaitis, Vytenis (EU (govt) 201801 Commissioner for Health and Food Safety) |
Minister |
EU (govt) |
Belgium |
| Anninga, Bauke (Merck (DE) 202210 Principal at M Ventures) |
Principal (venture capital) |
Merck (DE) (Group) |
Netherlands |
| Anson, John (Oxford Gene Technology 200601–202203 before Amersham Biosciences/GE Healthcare RETIRED 4/22) |
Chief Executive Officer (CEO) |
Sysmex (Group) |
United Kingdom (GB) |
| Antay, Pamela (Eurofins 201609 Head Corp Communication + IR) |
Public Relations Manager / Investor Relations Manager |
Eurofins (Group) |
Luxembourg |
| Antener, Mathias (Creoptix 202201 Head of Marketing) |
Public Relations Manager / Investor Relations Manager |
Spectris (Group) |
Switzerland |
| Antonelli, Michele (UCB 201201– EVP + Managing Director UCB France before Head Technical Operations + Quality) |
Managing Director |
UCB (Group) |
Belgium |
| Antoni, Christian (Sanofi 201502 VP + Head Immunology + Inflammation Franchise RnD) |
President/Director/Head Business Group/Unit/Division |
Sanofi (Group) [since May 2011] |
France |
| Arabian, Bruno (Ulysse Communication 201807 before Milestones 201511) |
Public Relations Manager / Investor Relations Manager |
Ulysse Communication GIE |
France |
| Aranowska-Bablok, Anna (Joint Polish Investment Fund 201503 General Partner) |
General Partner (venture partner) |
Joint Polish Investment Fund (JPIF) (Group) |
Netherlands |
| Archinard, Philippe (Institu Mérieux 202101– EVP Technological Innovation + Scientific Partnerships before Transgene) |
Chief Executive Officer (CEO) |
Mérieux (Group) |
France |
| Arie, Jean-Philippe (Luxembourg (govt) 201803– Manager of BioHealth Cluster before Genopole) |
Cluster Manager |
Luxembourg (govt) |
Luxembourg |
| Arnold, Drew (Cartagenia 201203– VP Sales + BusDev North America before GenomeQuest/Gene-IT + Lion Bioscience) |
Sales Manager / Marketing Manager |
Agilent (Group) |
United States (USA) |
| Arnold, Jonathan (Qiagen 202409 VP + Head of Translation Science + Precision Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Netherlands |
| Arnold, Katja (MC Services 201309 CIRO Executive Director before Wilex AG + CAT Consultants) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Arslan, Aysu (Bio Inx 202412 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Bio Inx B.V. |
Belgium |
| Asanuma, Sakae (Otsuka 201705 President of Taiho Ventures) |
President/Director/Head Business Group/Unit/Division |
Otsuka (Group) |
United States (USA) |
| Asbjornsen, Laura (Forbion 202104– Head of Communications) |
Public Relations Manager / Investor Relations Manager |
Forbion (Group) |
Netherlands |
| Ashery, Yoram (NST NeuroSurvival Technologies 200808 CEO) |
Chief Executive Officer (CEO) |
Aposense Ltd. |
Israel |
| Ashton, Chris (Argenta Discovery 200508 CEO) |
Chief Executive Officer (CEO) |
Pulmagen Therapeutics Ltd. |
United Kingdom (GB) |
| Ashton, Mark (Evotec 200910 EVP Business Development) |
Business Development Manager / Strategy Manager |
Evotec (Group) |
Germany |
| Aspinall, Adam (Norgine 201107– Global Marketing Director before Amgen International Marketing Manager in Zug) |
Sales Manager / Marketing Manager |
Norgine (Group) |
Netherlands |
| Astley-Sparke, Philip (Forbion 201209– Venture Partner before Amgen + BioVex CEO since 2005 + JP Morgan) |
Venture Partner |
Forbion (Group) |
Netherlands |
| Atlas, Mark (Fluxion 200804 Director Sales) |
Sales Manager / Marketing Manager |
Fluxion Biosciences Inc. |
United States (USA) |
| Atrzadeh, Faranak (Curetis 201904 SVP Scientific Affairs + Marketing) |
Sales Manager / Marketing Manager |
OpGen (Group) |
Netherlands |
| Aubry, Xavier (Da Vinci Labs 2021– CEO + Founder) |
Chief Executive Officer (CEO) |
Da Vinci Labs SAS |
France |
| Audet, Juliette (NewAmsterdam Pharma 202404– CBO before Forbion + Novartis Venture Fund + McKinsey) |
Chief Business Officer (CBO) |
NewAmsterdam Pharma (Group) |
Netherlands |
| Autret, Arnaud (Illumina 202205– Head of European Operations at Illumina Ventures before M Ventures) |
Principal (venture capital) |
Illumina (Group) |
United States (USA) |
| Avery, Jason (Merus 201206– CBO before Affitech Head Bus Dev + Cambridge Antibody Technology CBO) |
Chief Business Officer (CBO) |
Merus (Group) |
Netherlands |
| Avinoam, Sapir (Teva 201608 VP + General Manager of Teva Israel) |
General Manager (management) |
Teva (Group) |
Israel |
| Awada, A. (Institut Jules Bordet 201105 Investigator) |
Researcher (university / research institute) |
Institut Jules Bordet |
Belgium |
| Azzam, Fouad (Life Sciences Partners 201509 Partner at US Office of LSP) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
United States (USA) |
| Bacher, Johannes (Curetis 201804 COO before Managing Director + Co-Founder) |
Chief Operating Officer (COO) |
OpGen (Group) |
Germany |
| Bader, Manuela (Probiodrug 201711 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Vivoryon (Group) |
Germany |
| Baeten, Kristoff (Monkeys not Donkeys 202204 CEO + Founder) |
Chief Executive Officer (CEO) |
QbD Group (Quality by Design) (Group) |
Belgium |
| Baeten, Sofie (Qbic 202203 Managing Partner) |
Managing Partner (investment firm) |
Qbic (Group) |
Belgium |
| Baijens, Ruben (Eindhoven Venture Capital Fund II 201903 Investment Director) |
Investment Manager |
Eindhoven Venture Capital Fund II (EVCF II) |
Netherlands |
| Bakker, Jan Willem (Gilde Investment 202409– Partner + Head of IR at Gilde Healthcare before Prime Ventures) |
Partner (venture partner) |
Gilde Investment (Group) |
Netherlands |
| Baldi, Alessandro (Protea Biosciences 201110– VP + General Manager before own consulting firm before PerkinElmer) |
General Manager (management) |
Protea Biosciences (Group) |
United States (USA) |
| Baldo, Marjolaine (Agendia 201712 Commercial VP EMEA) |
Sales Manager / Marketing Manager |
Agendia (Group) |
Netherlands |
| Balice-Gordon, Rita (Muna Therapeutics 202107 CEO) |
Chief Executive Officer (CEO) |
Muna Therapeutics (Group) |
Denmark |
| Balkema, Jurjen (Westburg BV 201307 Commercial Director + Co-owner) |
Chief Commercial Officer (CCO) |
Westburg (Group) |
Netherlands |
| Ballal, Rahul (Mediar Therapeutics 202303 CEO before Imara) |
Chief Executive Officer (CEO) |
|
|
| Ballerini, Maurizio (Proteomedix 202006– VP Market Development EMEA before MDxHealth + GenProbe + Stryker + Randox) |
Sales Manager / Marketing Manager |
Proteomedix AG |
Switzerland |
| Ballesteros, Kathrin (NLC Ventures 202111 Venture Partner formerly KBK Concept 201310) |
Partner (venture partner) |
NLC Ventures (Group) |
Netherlands |
| Balling, Rudolf (Univ Luxembourg 201207 Director of LCSB before GBF 200511) |
President/Director/Head Business Group/Unit/Division |
University of Luxembourg |
Luxembourg |
| Ballmer, Allison (Agilent 202101– SVP Strategy + Corporate Development joined 5/18 before Roche + Biocartis) |
Business Development Manager / Strategy Manager |
Agilent (Group) |
United States (USA) |
| Balthrop, Patrick J. (Apalachee Ventures 201602 Founding Prinicpal before Luminex 200405–2014 CEO) |
Principal (venture capital) |
Apalachee Ventures |
|
| Baltus, Thierry (Antigon 202112 CEO) |
Chief Executive Officer (CEO) |
Antigon S.A. |
Belgium |
| Balusson, Hervé (Olmix 201508 CEO + Founder + Board Director of Biotech France) |
Chief Executive Officer (CEO) |
Olmix (Group) |
France |
| Balzer, Heike (Noxxon 202209 SVP Finance) |
Chief Financial Officer (CFO) |
TME Pharma (Group) |
Germany |
| Bancel, Stéphane (Moderna 2011– CEO before bioMérieux 201010 CEO + Eli Lilly) |
Chief Executive Officer (CEO) |
Moderna (Group) |
United States (USA) |
| Bangs, Alex (Entelos 200502) |
n. a. |
Entelos (Group) |
United States (USA) |
| Barbazette, Chris (DNA Script 2ß22ß5– CCO before Resolve Biosciences + EAB Consulting + GenapSys + Agendia + Affymetrix) |
Chief Commercial Officer (CCO) |
Resolve Biosciences GmbH |
Germany |
| Barberich, Timothy J. (Sepracor 200602 CEO) |
Chief Executive Officer (CEO) |
Dainippon Sumitomo (Group) |
United States (USA) |
| Barbetsea, Kassandra (Lumicks 202104 PR + Marketing) |
Sales Manager / Marketing Manager |
Lumicks (Group) |
Netherlands |
| Bardin, Stephen (Atai Life Sciences 202206– Deputy CFO + CFO Designate before BridgeBio Pharma + Myovant Sciences) |
Chief Financial Officer (CFO) |
Atai Life Sciences (Group) |
Netherlands |
| Bardissi, Wafik (Minapharm –200704– CEO) |
Chief Executive Officer (CEO) |
Minapharm (Group) |
Egypt |
| Bardon, Christiana (UBS Oncology Impact Fund 201806 Managing Director) |
Managing Director |
UBS (Group) |
United Kingdom (GB) |
| Barél, Erna (BaseClear 1993– Managing Director + Founder) |
Managing Director |
BaseClear B.V. |
Netherlands |
| Barfod, Lars (Elsevier MDL 200510 CEO) |
Chief Executive Officer (CEO) |
Dassault Systèmes (3DS) (Group) |
United States (USA) |
| Barka, Günes (SunChrom 201003 Managing Director) |
Managing Director |
SunChrom Wissenschaftliche Geräte GmbH |
Germany |
| Barlow, Raymond (Ray) (Kiadis 202007– CBO before e-therapeutics + Amgen + Crucell Vaccines + AstraZeneca) |
Chief Business Officer (CBO) |
Kiadis (Group) |
United Kingdom (GB) |
![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
